HIV

Fast science—with all its warts—is making unprecedented progress in the fight against COVID-19.

The South African scientist fought for women’s access to healthcare in disadvantaged communities.

Under careful watch of the World Health Organization, doctors will test a range of COVID-19 therapies, including HIV and flu antivirals, blood plasma infusions, and traditional Chinese medicines.

The study showed that a vaccine combining a variety of immune-stimulating components was no more effective than a placebo.

A video chronicles the course of disease research and prompts questions about where scientists may focus their studies in the future.

The scientific community said goodbye to Sydney Brenner, Paul Greengard, Patricia Bath, and a number of other leading researchers this year.

The modification of three babies’ genes by He Jiankui drew widespread criticism from scientists.

Macrophages transport HIV-like particles into lymph nodes during infection.

The physician-researcher laid the groundwork for genetic cloning and led the US Food and Drug Administration as the country faced the AIDS crisis in the 1980s.

The research, led by Russian biologist Denis Rebrikov, has not led to the birth of gene-edited babies—yet.

The authors have requested a retraction of a paper that found people with the CCR5 Δ32 variant are more likely to die sooner.

The physician and researcher challenged the Chinese government over her findings of widespread hepatitis and HIV contamination during blood collection.

Scientists spent five years reconstructing what is now the oldest HIV-1 genome yet recovered.

The microbiomes of men who have sex with men are associated with greater immune system activation and promote elevated rates of viral infection in vitro.

Those with two copies of the Δ32 allele in the CCR5 gene are 21 percent more likely to die by age 76, although it’s not clear why.

A study of hundreds of gay couples finds that HIV-positive men taking antiretroviral medication don’t pass the virus to their partners, even when having unprotected sex.

A lack of resources ordinarily blocks young researchers on the continent from scholarly independence, but long-term support is no guarantee.

The “London patient” may represent the second person cured of the infection by a cell transplant.

Donald Trump announced a plan to drastically cut HIV transmission by 2030, but some scientists and nonprofits aren’t sure the administration will follow through.